Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2002
10/31/2002WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002WO2002085897A1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/31/2002WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002WO2002085892A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002WO2002085890A1 Benzimidazolone derivatives
10/31/2002WO2002085889A1 Crystalline form of omeprazole
10/31/2002WO2002085888A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
10/31/2002WO2002085883A1 Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors
10/31/2002WO2002085868A1 Benzoxazinone derivatives for use in the treatment of angiogenesis
10/31/2002WO2002085866A1 Novel compounds
10/31/2002WO2002085861A1 Imidazolidine compounds and their use as cxcr3 antagonists
10/31/2002WO2002085860A1 Pyrazole derivatives for treating hiv
10/31/2002WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002WO2002085857A2 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
10/31/2002WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002WO2002085853A2 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002WO2002085850A1 Cyclic amidine derivative
10/31/2002WO2002085839A1 Fused bicyclic or tricyclic amino acids
10/31/2002WO2002085827A1 Extract from the pods of lupin seeds containing lupeol
10/31/2002WO2002085459A2 Antiangiogenic combination therapy for the treatment of cancer
10/31/2002WO2002085458A2 Use of nk-1 receptor antagonists against benign prostatic hyperplasia
10/31/2002WO2002085414A2 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
10/31/2002WO2002085413A1 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same
10/31/2002WO2002085412A1 Tissue fibrosis inhibitors
10/31/2002WO2002085407A1 Method of optimizing growth hormone replacement
10/31/2002WO2002085405A2 COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF$g(a)
10/31/2002WO2002085402A1 Methods and compositions for treating oral and eosophageal lesions
10/31/2002WO2002085399A1 Peptide-containing preparations
10/31/2002WO2002085387A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
10/31/2002WO2002085386A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002WO2002085385A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
10/31/2002WO2002085384A2 Lubricious coatings for substrates
10/31/2002WO2002085378A1 Low salt forms of polyallylamine
10/31/2002WO2002085372A1 Medicines and medicinal kits
10/31/2002WO2002085368A2 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders
10/31/2002WO2002085365A1 Tricyclic compounds useful as hiv reverse transcriptase inhibitors
10/31/2002WO2002085357A1 Nociceptin analogs
10/31/2002WO2002085354A1 Spiroindene and spiroindane compounds
10/31/2002WO2002085351A1 Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer
10/31/2002WO2002085346A1 Use of creatine for the amelioration of oxidative stress
10/31/2002WO2002085340A2 Oligonucleotide compositions and their use to induce differentiation of cells
10/31/2002WO2002085337A1 Micellar drug delivery systems for hydrophobic drugs
10/31/2002WO2002085330A1 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/31/2002WO2002085328A2 Method for producing an active ingredient concentrate, and an active ingredient concentrate
10/31/2002WO2002085305A2 Compositions and methods for inducing cancer cell death
10/31/2002WO2002085299A2 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002WO2002076935A8 Novel a-lipoic acid derivative and use thereof
10/31/2002WO2002070565A9 High-affinity antagonists of elr-cxc chemokines
10/31/2002WO2002068585A3 Tip39 polypeptides
10/31/2002WO2002068390A8 Diamides which inhibit tryptase and factor xa activity
10/31/2002WO2002068381A3 Aryl-n-cyanoguanidines and methods related thereto
10/31/2002WO2002067654A3 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
10/31/2002WO2002066681A9 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
10/31/2002WO2002061105A9 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
10/31/2002WO2002060949A3 Glycoforms a fas ligand inhibitory protein analog
10/31/2002WO2002055547A9 Sfrp and peptide motifs that interact with sfrp and methods of their use
10/31/2002WO2002053564A3 Quinuclidine derivatives and their use as m3 antagonists
10/31/2002WO2002051855A3 Motilide compounds
10/31/2002WO2002049650A3 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/31/2002WO2002042412A3 Protease inhibitors and their pharmaceutical uses
10/31/2002WO2002034913A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/31/2002WO2002030415A9 Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
10/31/2002WO2002028874A3 Tumor proliferation inhibitors
10/31/2002WO2002022611A3 Caspase inhibitors and uses thereof
10/31/2002WO2002014499A3 Claudin polypeptides
10/31/2002WO2002012502A3 Anti-tnf antibodies, compositions, methods and uses
10/31/2002WO2002000262A3 Modulation of chromosome function by chromatin remodeling agents
10/31/2002WO2001098343A3 Conserved diaphanous-related formin autoregulatory domain (dad)
10/31/2002WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002WO2001058479A9 Immunotherapy using interleukin 13 receptor subunit alpha 2
10/31/2002WO2001056563A9 Adamantyl derivatives as anti-cancer agents
10/31/2002WO2001055432A3 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications
10/31/2002WO2001053342A9 Chimeric prostate-homing peptides with pro-apoptotic activity
10/31/2002WO2001044243A3 Novel heteroaryl-diazabicycloalkanes
10/31/2002US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002US20020161220 Tetraphosphonate bicyclic trisanhydrides
10/31/2002US20020161200 For therapy
10/31/2002US20020161191 Novel Imidazoline receptor homologs
10/31/2002US20020161053 Inflammatory cytokine production inhibitors, matrix metalloprotease production inhibitors, inflammatory cell adhesion molecules incidence inhibitors, antiinflammatory agents
10/31/2002US20020161042 Nitric oxide donor composition and method for treatment of anal disorders
10/31/2002US20020161038 Inosine 5'-monophosphate dehydrogenase (IMPDH); prodrug having functional group -CO-N(-R)-COO-, a carrier, and an immunosuppressant, anticancer agent, antiviral agent, or anti-vascular hyperproliferation agent
10/31/2002US20020161035 Medicaments for chemotherapeutic treatment of disease
10/31/2002US20020161033 Substituted 1,5-dihydropyrrol-2-one derivatives active as NMDA receptor antagonists for treatment of states of pain
10/31/2002US20020161030 Sulpur derivatives containing a retroamide bond as inhibitors of endothelin-converting enzymes
10/31/2002US20020161025 N-substituted indole-3glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
10/31/2002US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition
10/31/2002US20020161022 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/31/2002US20020161020 Stablization of quinapril using magnesium oxide
10/31/2002US20020161019 For treatment of depression, anxiety, feeding disorders, headache, drug addiction, inflammatory disorders
10/31/2002US20020161016 As-needed administration of tricyclic and other non-SRI antidepressant drugs to treat premature ejaculation
10/31/2002US20020161014 Purinyl substituted quinazoline-4-one derivatives
10/31/2002US20020161010 Treatment of various disorders associated with enhanced activity of kinase p38-alpha and/or transforming growth factor beta; antiinflammatory agents
10/31/2002US20020161009 Use of selective antagonists of the alpha1b-adrenergic receptor for improvement of sexual dysfunction
10/31/2002US20020161008 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression
10/31/2002US20020161006 1,4-dihydropyridine compounds as bradykinin antagonists
10/31/2002US20020161004 Antiinflammation agents
10/31/2002US20020161001 Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV
10/31/2002US20020161000 Treating diseases resulting from tissue breakdown such as heart disease, multiple sclerosis, osteo- and rheumatoid arthritis, atherosclerosis, and osteoporosis
10/31/2002US20020160997 Novel indole derivatives
10/31/2002US20020160987 Novel 4-dedimethylaminotetracycline derivatives
1 ... 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 ... 1564